HC Surgical Specialists Limited (SGX:1B1)

Market Cap	42.18M
Revenue (ttm)	19.38M
Net Income (ttm)	3.78M
Shares Out	153.38M
EPS (ttm)	0.02
PE Ratio	11.20
Forward PE	n/a
Dividend	0.02 (5.45%)
Ex-Dividend Date	Feb 28, 2025

Volume	2,300
Average Volume	40,530
Open	0.2750
Previous Close	0.2700
Day's Range	0.2750 - 0.2750
52-Week Range	0.2400 - 0.3100
Beta	0.00
RSI	44.41
Earnings Date	Jul 25, 2025

About HC Surgical Specialists

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other g...

• Industry: Offices and Clinics of Doctors of Medicine
• Founded: 2015
• Country: Singapore
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 1B1

Financial Performance

In 2024, HC Surgical Specialists's revenue was 19.05 million, a decrease of -1.03% compared to the previous year's 19.25 million. Earnings were 3.85 million, an increase of 31.76%.